About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Biocon Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
03-Oct-2024
30-Oct-2024
Quarterly Results
18-Jul-2024
08-Aug-2024
Quarterly Results
12-Apr-2024
16-May-2024
Audited Results & Final Dividend
10-Jan-2024
08-Feb-2024
Quarterly Results
09-Oct-2023
10-Nov-2023
Quarterly Results
21-Jul-2023
10-Aug-2023
Quarterly Results
24-Apr-2023
26-Apr-2023
Inter alia, to consider the issue of Secured, Redeemable, Non-Convertible Debentures on private placement basis, investment in securities to be issued by Biocon Biologics Limited and provision of guarantees/put options, amongst other matters.
20-Apr-2023
23-May-2023
Final Dividend & Audited Results & A.G.M.
06-Jan-2023
14-Feb-2023
Quarterly Results
20-Oct-2022
14-Nov-2022
Quarterly Results
01-Jul-2022
27-Jul-2022
Quarterly Results
04-Apr-2022
28-Apr-2022
Audited Results & Dividend
03-Jan-2022
20-Jan-2022
Quarterly Results
05-Oct-2021
21-Oct-2021
Quarterly Results
06-Jul-2021
22-Jul-2021
Quarterly Results
12-Apr-2021
28-Apr-2021
Final Dividend & Audited Results
05-Jan-2021
21-Jan-2021
Quarterly Results
06-Oct-2020
22-Oct-2020
Quarterly Results
07-Jul-2020
23-Jul-2020
Quarterly Results
22-Apr-2020
14-May-2020
Audited Results
Page
1
of
5
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.